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ABSTRACT
Introduction: Recurrent miscarriage (RM) is
diagnosed when a woman has had three or more
miscarriages. Increased levels of distress and anxiety
are common during the waiting period of any
subsequent pregnancies, posing a significant threat to
psychological well-being. However, only limited
support and therapy are available for these women,
and many are left to cope alone. The Positive
Reappraisal Coping Intervention (PRCI) is a novel self-
administered supportive technique which has been
shown to be effective in patients awaiting the outcome
of in vitro fertilisation treatment. The primary objective
of this study is to assess the feasibility and
effectiveness of the PRCI in improving quality of life in
the difficult waiting period which women with previous
RM endure before an ongoing pregnancy can be
confirmed.
Methods and analysis: A randomised controlled
trial (RCT) feasibility study will establish the viability of
conducting a multicentre RCT to definitively test the
effects of the PRCI on the psychological well-being of
women who have experienced RM during the initial
waiting period of a subsequent pregnancy. A second
component consists of a qualitative process evaluation
exploring the initial experience of pregnancy following
repeated miscarriages. Participants (n=50) will be
randomised into one of two groups. The PRCI
intervention group will receive the PRCI card and
weekly questionnaires to assess their psychological
well-being during the waiting period of their new
pregnancy. The non-intervention group will be asked to
complete the same weekly questionnaires. The
qualitative process analysis will employ semistructured
interviews (n=20) to address relevant aspects of the
study objectives.
Ethics and dissemination: Ethics approval has been
obtained from the National Research Ethics Service
Committee South Central—Hampshire A. Participating
centres have given National Health Service R&D
approval. Study findings will be disseminated through
peer reviewed journals, national and international
conferences and lay user groups.
Trial registration number: ISRCTN43571276. This
study was registered with the ISRCTN 18/02/2014
following adoption onto the United Kingdom Clinical
Research Network (UKCRN) portfolio. Recruitment of
the first participant occurred 04/02/2014.
BACKGROUND
Miscarriage is the most common adverse
outcome of pregnancy1 and recurrent miscar-
riage (RM), deﬁned as the loss of three or
more consecutive pregnancies,2 affects
approximately 1% of women. RM is a distres-
sing and traumatic condition, representing
more than a loss of a pregnancy; it evokes feel-
ings surrounding a lost baby, a lost future child
and a lost motherhood.3 Feelings of grief and
depression are common4–6 and previous
studies have suggested that single and RM can
cause the affected woman a ‘signiﬁcant phys-
ical and psychological challenge’7 posing a
considerable threat to psychological well-
being.8 Despite these potential grieving
responses, women who experience miscarriage
tend not to receive the same level of
Strengths and limitations of this study
▪ This study will test a validated tool in a rando-
mised controlled trial providing essential feasibil-
ity information to inform a definitive fully
powered study.
▪ Addresses a novel area of research not previ-
ously investigated.
▪ This mixed-method study uses participant quali-
tative interviews to supplement feasibility data
providing additional insight into how women
experience the waiting period of a new preg-
nancy following recurrent miscarriage.
▪ Feasibility study not powered for a definitive
study.
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psychosocial support afforded to people experiencing
other types of bereavement.1
Studies investigating emotional morbidity in women in
the time period following miscarriage9–11 have indicated
that increased levels of anxiety and depression are often
experienced by women with a history of reproductive
loss during subsequent pregnancies.4 8 However,
research data pertaining to the psychological morbidity
associated with the difﬁcult period in a subsequent preg-
nancy as the woman waits to see whether the pregnancy
will again end in miscarriage or not, is scarce. The
experience of RM frequently results in a period of
‘marked stress reaction’12 when the woman becomes
pregnant again, speciﬁcally during the ‘waiting period’
between a positive pregnancy test and conﬁrmation that
the pregnancy is ongoing. Indeed, some women will
elect not to conceive at all rather than repeatedly face
this period of troubling uncertainty.
The medical waiting period
Waiting periods have been deﬁned as the period of time
in which patients are waiting for medical test results
which could be potentially threatening to their well-
being.13 The medical waiting period can be a psycho-
logically stressful time14 and Osuna15 proposes that
during the waiting period a psychological reaction can
occur whereby anticipation of loss leads to anxiety and
potential psychological distress. The medical waiting
period has been studied among a range of patient
groups including women waiting for genetic informa-
tion,16 women waiting for a breast cancer diagnosis,17
patients waiting for gastrointestinal endoscopy investiga-
tions,18 and the waiting period during fertility treatment
between embryo transfer (in vitro fertilisation, IVF) and
pregnancy test.19 A further study by Boivin and
Lancastle13 has shown that medical waiting periods have
a distinct emotional signature.
The waiting period of a new pregnancy
In the context of a pregnancy after RM, the waiting
period refers to the ﬁrst 12 weeks of a pregnancy when
women wait for ultrasound conﬁrmation that their preg-
nancy is ongoing. This can be a particularly stressful and
anxious time as the worry for the affected woman and
her partner often increases substantially. Any excitement
brought about by a positive pregnancy test is often over-
shadowed by the fear and despair that they will suffer
yet another miscarriage. Once the woman has reached
12 weeks of pregnancy and an ultrasound scan has con-
ﬁrmed this, the chance of progression to term is around
95% and this reassurance is likely to make her feel more
conﬁdent in her continuing pregnancy, and will experi-
ence less anxiety and distress.
There is a small but growing body of research con-
cerning the waiting period experienced by women who
have suffered RM. Recent evidence from a qualitative
focus group study,3 for example, provides insight into
the coping styles and experiences of women who have
suffered miscarriages, focusing on the initial waiting
period (eg, weeks 1–12) of a subsequent pregnancy.
Differences were found in the way women with one mis-
carriage and women with RMs appraised and assessed
the waiting period, but the coping strategies utilised in
both groups were similar. These were most commonly
emotion focused, and included avoidance, the seeking
of social support, distraction and the utilisation of posi-
tive appraisal.
Positive reappraisal and the positive reappraisal coping
intervention
Positive reappraisal coping is an active strategy20 21
which aims to reduce the emotional morbidity of a
stressful period by focusing on the positive aspects of a
situation. Positive reappraisal means choosing to take
account of good aspects alongside the negative aspects
of a situation, appreciating that even the most challen-
ging difﬁcult situations will have some positive
elements.19
Previous studies have identiﬁed that positive
reappraisal has been successful at reducing stress levels
for many patient populations including those suffering
from breast cancer,22 myocardial infarction23 and brain
injury,24 and in caregivers whose partners were termin-
ally ill with AIDS.25 In recent years, a theoretically
derived, short, coping, intervention based on the
concept of positive reappraisal has been developed, ini-
tially for use during the time period in which women
wait for the results of their pregnancy test following fer-
tility treatment.19 This intervention, called the Positive
Reappraisal Coping Intervention (PRCI) was designed
to stimulate positive reappraisal coping during the
waiting period between IVF and a pregnancy test and
aimed to encourage the consideration of positive aspects
of the situation and its meaning for the patient. The
study19 concluded that the women favourably evaluated
the PRCI and found it acceptable and beneﬁcial in
terms of supporting positive feelings during the IVF
waiting period, and sustaining their efforts to cope.
One of the key advantages of the PRCI approach is
that it is convenient for patients and is easily deliverable
at negligible cost. It comprises of an explanatory leaﬂet
describing positive reappraisal coping and its potential
beneﬁts as well as 10 statements printed on a laminated
card that users read at least twice a day to stimulate the
use of this form of coping. Since use of the PRCI does
not require clinic or hospital attendance or the direct
involvement of a carer or health professional, it is very
low in cost. Lancastle and Boivin19 demonstrated that
despite the fact that the women had minimal contact
with clinical or research staff during the waiting period,
the intervention was still positively evaluated.
For women who have experienced RM, the waiting
period in the early stages of pregnancy shares many
characteristics and stress factors with the waiting period
after fertility treatment. Both waiting periods include out-
comes which are unpredictable, outcomes over which the
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woman has no control, and a waiting period which lasts
several weeks. Both groups of patients may experience an
increase in anxiety and worry and acute uncertainty
about the outcome of this waiting period. Signiﬁcantly,
the psychological strain experienced by both groups and
their partners is compounded by concerns and doubts
about their ability to carry a successful pregnancy, a
future child and their ability to become parents. The two
groups of women share closely analogous experiences,
and similarities between the characteristics and stress
factors experienced in the two types of waiting period
suggest that the PRCI is potentially valuable as well as
cost-effective intervention for women during the initial
waiting period of a new pregnancy. This proposed rando-
mised controlled trial (RCT) feasibility and acceptability
study of the intervention is the next step in assessing the
suitability of the PRCI as a coping intervention for
women who have experienced RM.
PLAN OF INVESTIGATION
Study design
A mixed-method, two-centre, randomised controlled
feasibility study aims to establish the viability of conduct-
ing a multicentre RCT to deﬁnitively test the effects of
the PRCI on the psychological well-being of women who
have experienced RM during the initial waiting period
(1–12 weeks) of a subsequent pregnancy. Part 1 of this
study will address how acceptable the proposed methods
of recruitment and randomisation are: whether it is pos-
sible to achieve acceptable recruitment and retention
rates; whether the proposed data collection methods are
appropriate; whether the study time-points are appropri-
ate; and whether there is any preliminary effect of the
PRCI.
Part 2 of the study consists of a qualitative process
evaluation which aims to explore women’s subjective
experiences of the study intervention and research
methods (including study outcome measures), provide
information to reﬁne the study intervention (if
required), and to strengthen in-depth understanding of
the initial experience of pregnancy following repeated
miscarriages.
Intervention
The PRCI consists of an explanatory leaﬂet and a small
card containing 10 positive reappraisal statements that
aim to encourage users to redeﬁne the waiting period
more positively. The leaﬂet provides concise guidance
on the use of the PRCI. Speciﬁcally, women are encour-
aged to read the PRCI at least twice a day, in the
morning and in the evening, and any other time of day
they feel the need. When reading the statements,
women are instructed to consider and think about how
each statement relates to them personally. They are
advised that thinking about the positive aspects of a difﬁ-
cult situation does not mean pretending that ‘everything
is wonderful’ when they do not think it is, or ignoring
the negative aspects of a difﬁcult situation, but taking
account of the positive aspects alongside the more nega-
tive aspects of the situation. The positive aspects of the
waiting period will differ depending on personal circum-
stances, and the leaﬂet gives examples (eg, focusing on
the support and kindness friends and family have shown
during their difﬁculties or how their relationship with
their partner has strengthened because of the shared
experience).
The statements on the card are general and do not
refer to any one speciﬁc positive aspect, as individual
users will have very different ideas about what is or is
not positive. The women will be encouraged to put the
small card in a purse or pocket so that they are able to
remind themselves of the positive reappraisal techniques
wherever and whenever they feel the need. The leaﬂet
advises that the positive reappraisal technique can feel
strange at ﬁrst, but that the technique becomes easier
the more it is practiced.
Target population
The study population will consist of patients attending
the Recurrent Miscarriage Clinic and the Early
Pregnancy Unit at two regional hospitals in the south of
England. Women who have experienced three or more
miscarriages will be invited to participate, as this popula-
tion is at greater risk of high levels of anxiety and dis-
tress, as described previously.
Inclusion and exclusion criteria
Inclusion criteria will be: women with three or more mis-
carriages, women aged >18 years, and those who are
willing and able to give written consent. Women will be
excluded from this study if they do not speak English
well enough to understand and complete study materi-
als. This criterion is in place because the study materials
(including PRCI) are not currently available in
translation.
Feasibility RCT study
Proposed sample size and sampling strategy
Since this is a feasibility study which will indicate treat-
ment effect for the design of a deﬁnitive study, the
sample size is not determined by a power calculation.
The study sample will consist of two groups: the inter-
vention group will receive the PRCI in addition to the
current recommended care pathway, and the control
group will follow the current recommended care
pathway. A maximum of 25 patients will be recruited to
each of the treatment arms over a 12-month period.
There will be a lag time from recruitment (when the
women experience their most recent miscarriage) to
randomisation (when the participants inform the study
team that they have a positive pregnancy test). This
period, however, is likely to be relatively short, as many
women who experience RM become pregnant quickly
and have a short ‘time-to-pregnancy’,26 despite difﬁculty
carrying the pregnancy to term. Two of the aims of this
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study, however, are to investigate patient ﬂow for an
actual recruitment rate to this study and the time lag
from recruitment to randomisation.
Recruitment and randomisation
Potential participants will be given information about
the study by their clinical care team when they attend
the Recurrent Miscarriage Clinic or Early Pregnancy
Unit and are invited to take part. If they agree, partici-
pants will be asked to consent to take part in the study
prior to becoming pregnant. Informed consent will be
obtained by the researcher or research midwife assigned
to the study. The participants will be invited to contact
the researcher as soon as possible after a positive preg-
nancy test to enable randomisation, the aim being to
achieve randomisation the same day or as soon after as
possible. A card with the researcher’s contact details will
be provided. Randomisation into one of the two study
groups will be carried out by the study statistician using
an independent computerised randomisation system
with a randomly sized block design with block sizes of 2,
4 and 6. The study population will be stratiﬁed for those
receiving concurrent treatment for RM, those with
underlying medical conditions which are causative of
RM, and number of previous miscarriages.
Participants will be randomised into one of the two
study groups. The intervention group will be asked to
use the PRCI and receive a weekly questionnaire assess-
ment from the date of a positive pregnancy test until
12 weeks of pregnancy. The PRCI will be sent to the par-
ticipant at randomisation. The control group will receive
a weekly questionnaire assessment from the date of a
positive pregnancy test until 12 weeks of pregnancy.
If a participant experiences a further miscarriage
during the study period, they will be asked to notify the
researcher. Questionnaire data from women who experi-
ence another miscarriage before 12 weeks of pregnancy
analysis will be included in the data analysis.
Questionnaires will be returned by post to the
research team monthly in prepaid envelopes.
For the purposes of this study, the waiting time period
has been deﬁned as the period from a positive preg-
nancy test until 12 weeks of pregnancy. An early preg-
nancy ultrasound scan is normally performed at
approximately 12 weeks gestation, as part of routine
antenatal care throughout the UK.
Materials
Preintervention demographic questionnaire
This questionnaire will be used to obtain demographic
information (eg, age, educational status), medical condi-
tions (eg, comorbidity associated with RM), gynaeco-
logical history (eg, fertility history) and reproductive
history (eg, live births and dates and number of miscar-
riages) in order to appraise the clinical characteristics of
study participants.
The following questionnaires will be completed from
randomisation, that is, on the day of a positive
pregnancy test and then at weekly intervals until the
woman is 12 weeks pregnant:
Hospital Anxiety Depression Score (HADS):27 This ques-
tionnaire is commonly used by clinicians to determine
the levels of anxiety and depression a patient is experi-
encing. The HADS consists of 14 items (7 items for each
of the subscales relating to anxiety and depression) and
rated on a four-point Likert scale; the total score is the
sum of the 14 items, and the subscale score is the sum
of the respective seven items. The scores on each sub-
scale are interpreted in ranges 0–7 (normal), 8–10
(mild), 11–14 (moderate) and 15–21 (severe).
The Daily Record Keeping Form (DRK)28 will be used to
assess emotions, appraisals, coping and physical symp-
toms experienced during the waiting period. The ori-
ginal measure was developed for daily assessments, but
due to the burden of daily monitoring and potential
reactivity as reported in prior research using the PRCI
tool29 the DRK will be used only at weekly intervals in
the current study. To avoid confusion for research parti-
cipants it will be called the ‘Weekly Record Keeping
Form’ for the duration of the study. The DRK has been
shown to be sensitive to changes in emotional13 and
physical reactions28 during the waiting period prior to a
pregnancy test.
Data analysis
Descriptive statistics with CIs will be used to explore the
feasibility of the study procedures (numbers of eligible
women, recruitment and retention rates, missing data)
for each centre. Psychological well-being measures and
the DRK will be summarised, and changes over the time
course of the study examined descriptively. The relation-
ship between physical symptoms, psychological well-
being, appraisals and coping will also be explored
descriptively using methods such as graphical displays.
An assessment of any indication of an intervention
effect will be made, but this will be viewed with caution
given that this is a feasibility study. The variation of the
psychological measurements within the control group
will be used to inform power calculations for a future
RCT, should this be warranted.
Qualitative process evaluation
The qualitative process evaluation will employ semistruc-
tured interviews using a topic guide to address relevant
aspects of study objectives.
Proposed sample size and sampling strategy
Participants will be selected purposively, based on study
group, that is, control or intervention, ongoing preg-
nancy or miscarriage, and clinically important demo-
graphics including age, comorbidity/medical conditions
and previous live births. This method of sampling is
commonly used in qualitative research30 and is a means
of collecting perspectives from as diverse a group as pos-
sible, which is particularly important when trying to
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understand whether an intervention is acceptable to a
population.
Sample sizes in qualitative studies vary31 and tend to
aim for data saturation, that is, that point at which no
new information is found, as the ideal. In this study, in
which the aim is to study participants’ experience of
study processes, rather than the development of
explanatory theory, a maximum of 20 participants will
be interviewed unless saturation is deemed to be
achieved before this point, as it is likely a sample of this
size will provide sufﬁcient data to identify key issues and
themes.
Data collection
Data will be collected using face-to-face, semistructured
interviews and will take place at a location convenient
for the participant. All the interviews will be performed
by SB. Interviews will follow a topic guide which will be
developed based on the study aims, a previous PRCI
evaluation tool, a review of current literature, and discus-
sion with Patient Public Involvement representatives and
the supervisory team. The interview will last no longer
than 60 min and will be audio-recorded and transcribed
verbatim.
Participants will be eligible for interview once they
reach 12 weeks of pregnancy and have completed the
use of the PRCI and weekly questionnaire assessment, or
in the case of the control group, weekly questionnaire
assessment. If a participant experiences a further miscar-
riage they may still be approached for interview, but care
will be taken to allow a suitable time period to elapse
before this is arranged.
Data analysis
The aim of qualitative analysis is to unravel the plethora
of data and make sense of the phenomena under investi-
gation. Most qualitative approaches involve some degree
of thematic analysis, and although thematic analysis can
be as simple or complex as the research study demands,
it is a more complicated process than merely coding and
categorising data, and requires the researcher to ask
more complex questions such as how the codes relate to
each other.32 Therefore, in order to promote and facili-
tate a more systematic and robust analysis of the inter-
view data and to aid in its presentation, the transcripts
will be subjected to a thematic analysis using the frame-
work approach.33 This approach was developed speciﬁc-
ally to meet information needs and to provide outcomes
or recommendations, and offers a highly visible and sys-
tematic approach to data analysis, showing very clearly
how ﬁndings are derived from the data. It allows for
both an inductive and exploratory approach, as other
forms of qualitative analysis do, so that the integrity of
individual accounts is preserved, but is also designed to
facilitate analysis of speciﬁc concepts and issues that are
particularly important to address, as in the proposed
process evaluation.34
In order to further promote integrity and reliability
during the data analysis process, other strategies will be
introduced. Field notes will be written immediately after
the interview and a reﬂective diary maintained, aiming
to reduce the potential for the researcher’s values,
beliefs and preconceptions to inﬂuence subsequent ﬁnd-
ings.35 Coding and analysis of the qualitative data will be
completed by the researcher. In order to monitor and
limit subjectivity, two members of the research supervi-
sion team will examine parts of the transcripts to
compare their perceptions of the interview data and
analysis with the researcher’s interpretation.
DISCUSSION
RM is an extremely distressing condition. Even after
thorough investigation, aetiological causes can be found
in only 50% of cases.2 Frequently, the cause is elusive or
multifactorial,36 leading to intense frustration for the
affected woman and her healthcare team, as there is cur-
rently no effective treatment or therapy which can be
offered. In order to address this condition appropriately
and effectively, there is a need to develop a greater
understanding of the causes, treatment and effects of
RM. Current research into RM focuses on aetiology and
the development of medical interventions to treat the
condition. Other studies have reviewed the use of inter-
ventions to alleviate distress in the period immediately
following miscarriage5 37 but there is insufﬁcient evi-
dence relating to the effectiveness of support during the
initial waiting period of a subsequent pregnancy3 or the
way in which such support should be delivered. This
study is the ﬁrst step in a programme of research con-
cerned with improving psychological well-being for
women affected by RM during the early stages of a new
pregnancy; a waiting period which previous studies have
indicated is associated with high levels of anxiety and
distress for the affected woman, but a time period when
there is limited support and therapy available. As such, it
is envisaged that this research will both enhance and
complement ongoing studies within a wider programme
of research into the care and management of women
who experience RMs.
This study is both timely and topical, investigating an
issue which causes distress and anxiety to women
affected by RM, and one which is proving a challenge to
the healthcare professionals caring for them. The study
will add valuable information to the body of evidence
relating to how women who have suffered RM experi-
ence the waiting period of a new pregnancy.
Additionally, the evaluation of the acceptability and
feasibility of the PRCI will explore and identify how
women who have experienced RM utilise this type of
self-administered tool. If the PRCI proves to be an
acceptable and valuable intervention then this model of
care has the potential to be made more widely available
within the National Health Service, both locally and
nationally, as an effective, low cost, convenient, safe and
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easily deliverable intervention. The primary objective of
this study, which lays the foundation for possible future
trials, is to complete a necessary preliminary stage in the
process of testing the effectiveness of the PRCI in
improving quality of life for women in the initial
12 weeks of pregnancy following repeated miscarriages.
The PRCI has the potential to provide a low-cost inter-
vention to provide much needed support to a vulnerable
patient population.
Ethical considerations
This research will involve a potentially vulnerable patient
group that has experienced RM. Care will be taken from
the outset to ensure the health and well-being of the
research participants, and they will be reminded that
their participation is entirely voluntary and that they are
free to withdraw at any time without their healthcare
being affected. Potential participants will be given as
much time as they need to decide whether they wish to
take part in the study, and appropriate informed
consent procedures will be adhered to.
Previous studies have demonstrated that women using
the PRCI, strongly recommend its use to others,19 and
that women who had experienced miscarriage did not
report any negative experiences from using the PRCI.3 As
such, any negative effects regarding the safety and well-
being of participants in this study due to the speciﬁc use
of the PRCI are not anticipated. Qualitative interviews
will be arranged at a convenient time and location for the
participant and will be conducted in a sensitive manner.
If the participant shows any sign of fatigue or distress,
then the interview will be stopped and either concluded,
or agreement sought to resume at a later date.
Although this study is investigating a sensitive subject
with a potentially vulnerable group, previous experience
of researching sensitive topics in reproductive health
suggests that women appreciate the opportunity to con-
tribute to an important and personally relevant ﬁeld of
investigation.
Trial management and monitoring
Trial management meetings will be held every 6 weeks
between the researcher and the supervisory team to
discuss study progress. Additionally, a steering group con-
sisting of the researcher, the academic supervisors and
the two members of the patient and public representative
team will meet six monthly to scrutinise and review pro-
gress of the research. Financial management of the study
will be overseen by the Research and Development
Finance Manager, University Hospital Southampton.
Dissemination
Study ﬁndings will be disseminated to study participants
and through peer reviewed journals/publications, and
national and international conference presentations.
The Miscarriage Association has agreed to disseminate
and publish study ﬁndings to the public and lay groups
through their website.
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